Determination of macro and trace element levels of serum, tears, saliva, and hair samples in kilis goats with icp-ms

This study is focused on the evaluation of macro and trace elements concentration including sodium (Na), potassium (K), calcium (Ca), magnesium (Mg), iron (Fe), copper (Cu), zinc (Zn), selenium (Se), nickel (Ni), titanium (Ti), manganese (Mn), cobalt (Co), and chromium (Cr) of the serum, saliva, tears, and hair samples in Kilis goats. The study involved 33 goats without clinical signs of disease. Individual serum, saliva, tears, and hair samples from each goat were collected for element quantifications through the inductively coupled plasma mass spectrometry (ICP-MS) method after acid digestion in a microwave system. Element concentrations varied and depended on the sample type. The most predominant element in serum and saliva samples was Na (3559±55.2 and 3265±53.6 mg/L, respectively), followed by K>Ca>Mg. Potassium was the most abundant element analyzed in tears and hair samples (3506±305 and 4664±100.5 mg/L, respectively). The major trace element was Fe in all sample types except hair samples. Nickel was detected only in serum samples (83.9±6.35 μg/L) and Mn was detected only in hair samples (12903±3142 μg/L). In all samples, Co was below the detection limit. There was a significant correlation of some elements between serum and hair (Na, K, Mg, Cu), tears and hair (K, Mg, Fe), serum and tears (K) samples. Trace elements concentration did not pose a risk for deficiency or excess. It was concluded that tears and saliva are potential alternative materials for element analysis and simultaneous tears, saliva, and hair along with serum could be useful in predicting the inorganic metabolic status of goats

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

Investigation of the efficacy of clinoptilolite in calves with cryptosporidiosis

This study aims to investigate the efficacy of clinoptilolite in calves infected with Cryptosporidium. For this purpose, 30 animals monoinfected with Cryptosporidium and 10 healthy calves as a control group were included in the study, and in total four groups were formed. Fluid therapy was administered to all three groups to correct dehydration and acidosis of the calves. Clinoptilolite was administered to the first group at an oral dose of 1 g/day and an oral dose of 1 g/day and standard treatment was applied to the second group. The third group was treated with only standard treatment. Blood gas (pH, HCO3-, Na+, Cl-, K+, Crea, BE) and blood biochemistry (AST, ALT, BUN, Glucose) measurements and feces scoring by inspection method (1=watery, 2=pudding consistency, 3=soft, 4=hard) were applied to the study groups. Statistical evaluation of the variables examined in the calves was made in SPSS 24.0 package program. In the second group, there was a significant increase in pH, HCO3- (p 0.05). Feces scores of calves with diarrhea after treatment were statistically improved at p < 0.05 level in Groups 1 and 3, and at p < 0.01 level in Group 2. It was determined that there were 4 calves in the first group, 9 calves in the second group, and 7 in the third group which showed signs of improvement. As a result, it was concluded that, in addition to standard treatment, the inclusion of clinoptilolite at a daily dose of 1 g/kg orally for 5 days can contribute to the treatment of calves with Cryptosporidium, and that it is safe to be used on calves